Nov 3 (Reuters) - India's Bayer CropScience posted a nearly 9% rise in second-quarter profit on Tuesday, helped by lower ...

Bayer’s pharmaceutical business may finally be entering a long-awaited growth cycle, but CEO Bill Anderson still can’t quite ...

Bayer CropScience Ltd has announced an impressive 8.84% growth in net profit, totaling Rs 166.2 crore for Q2 FY27. However, total income saw a 19.4% decline year-over-year, attributed to ongoing ...

Bayer CropScience Limited (BSCL) reported a 9 per cent increase in its Q2FY27 profits at ₹166.2 crore against corresponding ...

Bayer CropScience Q2 FY27 revenue declined 19.5% to ₹1,250.7 crore, while profit before tax rose 6% to ₹211.4 crore. Board ...

Bayer says a news report claiming the company is trying to spin off its Crop Science division “is based purely on speculation.” The Platow Brief, a German business publication, said Friday it was ...

Bayer challenges industry to redefine canola innovation and reframe canola's future around real, lasting systems. CALGARY, Alberta--(BUSINESS WIRE)--Bayer Crop Science Canada launches Advancing Better ...

Bayer has seen its share price surge in recent months, which puts fresh attention on whether the current valuation lines up ...

Bayer AG is rated a Hold after a robust Q3, with Pharma outperforming expectations and driving operating leverage. Read more ...

Monheim – Bayer CropScience announced today that it has entered into an agreement to purchase Athenix Corp., a privately-held independent biotechnology company headquartered in Research Triangle Park, ...